Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study.

The potential of early interventions for dementia has increased interest in cognitive impairments less severe than dementia. However, predictors of the trajectory from intact cognition to dementia have not yet been clearly identified. The purpose of this study was to determine whether known risk factors for dementia increased the risk of mild cognitive impairments or progression from mild cognitive impairments to dementia. A polytomous logistic regression model was used, with parameters governing transitions within transient states (intact cognition, mild cognitive impairments, global impairment) estimated separately from parameters governing the transition from transient to absorbing state (dementia or death). Analyses were based on seven annual examinations (1991-2002) of 470 Nun Study participants aged > or = 75 years at baseline and living in the United States. Odds of developing dementia increased with age primarily for those with low educational levels. In these women, presence of an apolipoprotein E gene *E4 allele increased the odds more than fourfold by age 95 years. Age, education, and the apolipoprotein E gene were all significantly associated with mild cognitive impairments. Only age, however, was associated with progression to dementia. Thus, risk factors for dementia may operate primarily by predisposing individuals to develop mild cognitive impairments; subsequent progression to dementia then depends on only time and competing mortality.

[1]  D. Hogan,et al.  Predicting Who Will Develop Dementia in a Cohort of Canadian Seniors , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[2]  B. Gurland,et al.  The performance test of activities of daily living. , 1976, International journal of aging & human development.

[3]  H. Amièva,et al.  Annual Rate and Predictors of Conversion to Dementia in Subjects Presenting Mild Cognitive Impairment Criteria Defined according to a Population-Based Study , 2004, Dementia and Geriatric Cognitive Disorders.

[4]  Robert Tibshirani,et al.  An Introduction to the Bootstrap , 1994 .

[5]  D. Loewenstein,et al.  Mild cognitive impairment , 2003, Neurology.

[6]  L S Honig,et al.  Aging and Alzheimer's disease: lessons from the Nun Study. , 1998, The Gerontologist.

[7]  H. Feldman,et al.  Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging , 2004, Canadian Medical Association Journal.

[8]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[9]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[10]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[11]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIII. , 1996, Neurology.

[12]  R. Bucks,et al.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful , 2003, Journal of neurology, neurosurgery, and psychiatry.

[13]  E. Reiman,et al.  Vascular risk factors, incidence of MCI, and rates of progression to dementia , 2004, Neurology.

[14]  J. Touchon,et al.  Mild cognitive impairment: conceptual basis and current nosological status , 2000, The Lancet.

[15]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[16]  Gregory K. Miller,et al.  Elements of Applied Stochastic Processes , 1972 .

[17]  John Breitner,et al.  Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. , 2003, Archives of neurology.

[18]  J. Touchon,et al.  Classification criteria for mild cognitive impairment , 2001, Neurology.

[19]  Jong-Ling Fuh,et al.  Measuring Alzheimer's disease progression with transition probabilities in the Taiwanese population , 2004, International journal of geriatric psychiatry.

[20]  D R Wekstein,et al.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.

[21]  P. Celsis,et al.  Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? , 2000, Annals of medicine.

[22]  D. A. Bennett,et al.  Natural history of mild cognitive impairment in older persons , 2002, Neurology.

[23]  F. Schmitt,et al.  Models of progression in AD , 2001, Neurology.

[24]  W R Markesbery,et al.  Risk factors for transitions from normal to mild cognitive impairment and dementia , 2006, Neurology.

[25]  D. Schaid,et al.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.

[26]  ORDMKV: a computer program fitting proportional odds model for multi-state Markov process. , 1995, Computer methods and programs in biomedicine.

[27]  H. Feldman,et al.  Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. , 2004, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[28]  J Philip Miller,et al.  Rates of progression in mild cognitive impairment and early Alzheimer’s disease , 2002, Neurology.

[29]  David A. Snowdon,et al.  Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study , 2005, Neurobiology of Aging.

[30]  E. Tangalos,et al.  Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.

[31]  P. Diggle,et al.  Analysis of Longitudinal Data. , 1997 .

[32]  H. Soininen,et al.  Incidence and Risk Factors for Mild Cognitive Impairment: A Population-Based Three-Year Follow-Up Study of Cognitively Healthy Elderly Subjects , 2004, Dementia and Geriatric Cognitive Disorders.

[33]  D. Bennett,et al.  The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. , 2005, Neurocase.

[34]  Laura Fratiglioni,et al.  What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment , 2003, Acta neurologica Scandinavica. Supplementum.

[35]  R. Petersen.  MILD COGNITIVE IMPAIRMENT , 2004, Lancet.

[36]  K S Kosik,et al.  Measuring Alzheimer’s disease progression with transition probabilities , 2001, Neurology.

[37]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[38]  W. Markesbery,et al.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study , 2002, Annals of neurology.

[39]  J. Schneider,et al.  Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions , 2005, Neurology.

[40]  R W Pew,et al.  Simulated activities of daily living examination. , 1972, Archives of physical medicine and rehabilitation.

[41]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[42]  N. Butters,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.

[43]  R. Mayeux,et al.  Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. , 2005, Archives of neurology.

[44]  D. Bennett,et al.  The apolipoprotein E ϵ4 allele and incident Alzheimer’s disease in persons with mild cognitive impairment , 2005 .

[45]  David Snowdon,et al.  Aging with Grace: What the Nun Study Teaches Us About Leading Longer, Healthier, and More Meaningful Lives , 2001 .

[46]  E. Milwain.  Mild cognitive impairment: further caution , 2000, The Lancet.